Dynavax Begin Period Cash Flow vs Ev To Free Cash Flow Analysis

DVAX Stock

USD 12.96 0.03 0.23%

Dynavax Technologies financial indicator trend analysis is much more than just examining Dynavax Technologies latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dynavax Technologies is a good investment. Please check the relationship between Dynavax Technologies Begin Period Cash Flow and its Ev To Free Cash Flow accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Begin Period Cash Flow vs Ev To Free Cash Flow

Begin Period Cash Flow vs Ev To Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dynavax Technologies Begin Period Cash Flow account and Ev To Free Cash Flow. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Dynavax Technologies' Begin Period Cash Flow and Ev To Free Cash Flow is 0.88. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Ev To Free Cash Flow in the same time period over historical financial statements of Dynavax Technologies, assuming nothing else is changed. The correlation between historical values of Dynavax Technologies' Begin Period Cash Flow and Ev To Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Dynavax Technologies are associated (or correlated) with its Ev To Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Free Cash Flow has no effect on the direction of Begin Period Cash Flow i.e., Dynavax Technologies' Begin Period Cash Flow and Ev To Free Cash Flow go up and down completely randomly.

Correlation Coefficient

0.88

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Most indicators from Dynavax Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dynavax Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.At this time, Dynavax Technologies' Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 207.08 in 2024, whereas Tax Provision is likely to drop slightly above 945.2 K in 2024.

	2023	2024 (projected)
Interest Income	26.8M	28.1M
Non Recurring	15.4M	16.1M

Interest Income Non Recurring

Dynavax Technologies fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Other Assets	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Other Current Liab	Total Current Liabilities	Accounts Payable	Cash	Short Term Investments	Other Current Assets	Common Stock	Property Plant Equipment	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Property Plant And Equipment Gross	Total Current Assets	Net Receivables
Total Assets		0.85	-0.49	-0.22	0.93	0.81	0.86	0.74	0.61	0.13	0.83	0.8	0.64	0.19	0.91	0.92	0.62	0.11	0.84	0.74	0.97	0.22	0.87	0.88	0.97	0.84
Total Stockholder Equity	0.85		-0.21	-0.24	0.74	0.67	0.48	0.37	0.17	0.04	0.49	0.96	0.23	0.21	0.61	0.71	0.2	0.18	0.48	0.36	0.94	0.25	0.65	0.74	0.93	0.59
Retained Earnings	-0.49	-0.21		0.48	-0.73	-0.87	-0.63	-0.53	-0.46	-0.67	-0.45	-0.26	-0.42	0.02	-0.74	-0.7	-0.39	-0.36	-0.57	-0.49	-0.39	0.01	-0.6	-0.64	-0.41	-0.41
Other Assets	-0.22	-0.24	0.48		-0.25	-0.49	-0.14	-0.17	-0.18	-0.27	-0.21	-0.2	-0.16	-0.41	-0.28	-0.22	-0.16	0.08	-0.18	-0.16	-0.22	-0.41	0.01	-0.19	-0.21	-0.14
Common Stock Shares Outstanding	0.93	0.74	-0.73	-0.25		0.93	0.86	0.74	0.56	0.33	0.74	0.73	0.6	0.08	0.94	0.98	0.53	0.32	0.83	0.72	0.87	0.11	0.91	0.91	0.88	0.8
Other Stockholder Equity	0.81	0.67	-0.87	-0.49	0.93		0.72	0.58	0.43	0.53	0.59	0.69	0.43	0.08	0.88	0.89	0.4	0.37	0.67	0.55	0.77	0.11	0.79	0.87	0.79	0.6
Total Liab	0.86	0.48	-0.63	-0.14	0.86	0.72		0.89	0.87	0.19	0.93	0.43	0.86	0.12	0.95	0.86	0.85	0.01	0.95	0.9	0.73	0.13	0.85	0.77	0.75	0.84
Other Current Liab	0.74	0.37	-0.53	-0.17	0.74	0.58	0.89		0.91	0.1	0.93	0.23	0.93	0.09	0.79	0.69	0.86	-0.26	0.97	0.99	0.58	0.09	0.61	0.51	0.57	0.94
Total Current Liabilities	0.61	0.17	-0.46	-0.18	0.56	0.43	0.87	0.91		-0.04	0.93	0.03	0.98	0.13	0.73	0.55	0.99	-0.44	0.9	0.93	0.44	0.13	0.47	0.38	0.43	0.77
Accounts Payable	0.13	0.04	-0.67	-0.27	0.33	0.53	0.19	0.1	-0.04		-0.01	0.17	-0.13	-0.08	0.36	0.28	-0.1	0.54	0.08	0.02	0.12	-0.06	0.35	0.43	0.14	-0.03
Cash	0.83	0.49	-0.45	-0.21	0.74	0.59	0.93	0.93	0.93	-0.01		0.36	0.94	0.12	0.85	0.71	0.93	-0.34	0.95	0.94	0.72	0.13	0.65	0.58	0.7	0.88
Short Term Investments	0.8	0.96	-0.26	-0.2	0.73	0.69	0.43	0.23	0.03	0.17	0.36		0.08	0.2	0.59	0.72	0.07	0.4	0.36	0.22	0.91	0.24	0.71	0.81	0.91	0.44
Other Current Assets	0.64	0.23	-0.42	-0.16	0.6	0.43	0.86	0.93	0.98	-0.13	0.94	0.08		0.14	0.72	0.58	0.97	-0.44	0.92	0.96	0.48	0.13	0.48	0.38	0.46	0.84
Common Stock	0.19	0.21	0.02	-0.41	0.08	0.08	0.12	0.09	0.13	-0.08	0.12	0.2	0.14		0.09	0.12	0.15	-0.01	0.15	0.16	0.2	1.0	0.01	0.09	0.19	0.19
Property Plant Equipment	0.91	0.61	-0.74	-0.28	0.94	0.88	0.95	0.79	0.73	0.36	0.85	0.59	0.72	0.09		0.93	0.72	0.15	0.88	0.79	0.82	0.11	0.89	0.89	0.83	0.77
Property Plant And Equipment Net	0.92	0.71	-0.7	-0.22	0.98	0.89	0.86	0.69	0.55	0.28	0.71	0.72	0.58	0.12	0.93		0.54	0.37	0.81	0.69	0.85	0.15	0.93	0.94	0.87	0.76
Current Deferred Revenue	0.62	0.2	-0.39	-0.16	0.53	0.4	0.85	0.86	0.99	-0.1	0.93	0.07	0.97	0.15	0.72	0.54		-0.47	0.86	0.89	0.47	0.16	0.47	0.38	0.46	0.73
Net Debt	0.11	0.18	-0.36	0.08	0.32	0.37	0.01	-0.26	-0.44	0.54	-0.34	0.4	-0.44	-0.01	0.15	0.37	-0.47		-0.13	-0.27	0.15	0.01	0.47	0.51	0.2	-0.14
Non Current Assets Total	0.84	0.48	-0.57	-0.18	0.83	0.67	0.95	0.97	0.9	0.08	0.95	0.36	0.92	0.15	0.88	0.81	0.86	-0.13		0.98	0.69	0.16	0.73	0.65	0.69	0.95
Non Currrent Assets Other	0.74	0.36	-0.49	-0.16	0.72	0.55	0.9	0.99	0.93	0.02	0.94	0.22	0.96	0.16	0.79	0.69	0.89	-0.27	0.98		0.58	0.16	0.6	0.51	0.57	0.94
Cash And Short Term Investments	0.97	0.94	-0.39	-0.22	0.87	0.77	0.73	0.58	0.44	0.12	0.72	0.91	0.48	0.2	0.82	0.85	0.47	0.15	0.69	0.58		0.23	0.82	0.86	1.0	0.72
Common Stock Total Equity	0.22	0.25	0.01	-0.41	0.11	0.11	0.13	0.09	0.13	-0.06	0.13	0.24	0.13	1.0	0.11	0.15	0.16	0.01	0.16	0.16	0.23		0.04	0.12	0.22	0.19
Non Current Liabilities Total	0.87	0.65	-0.6	0.01	0.91	0.79	0.85	0.61	0.47	0.35	0.65	0.71	0.48	0.01	0.89	0.93	0.47	0.47	0.73	0.6	0.82	0.04		0.96	0.85	0.67
Property Plant And Equipment Gross	0.88	0.74	-0.64	-0.19	0.91	0.87	0.77	0.51	0.38	0.43	0.58	0.81	0.38	0.09	0.89	0.94	0.38	0.51	0.65	0.51	0.86	0.12	0.96		0.89	0.59
Total Current Assets	0.97	0.93	-0.41	-0.21	0.88	0.79	0.75	0.57	0.43	0.14	0.7	0.91	0.46	0.19	0.83	0.87	0.46	0.2	0.69	0.57	1.0	0.22	0.85	0.89		0.71
Net Receivables	0.84	0.59	-0.41	-0.14	0.8	0.6	0.84	0.94	0.77	-0.03	0.88	0.44	0.84	0.19	0.77	0.76	0.73	-0.14	0.95	0.94	0.72	0.19	0.67	0.59	0.71

Click cells to compare fundamentals

Dynavax Technologies Account Relationship Matchups

Dynavax Technologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	279.1M	353.3M	1.0B	985.9M	997.1M	1.0B
Total Stockholder Equity	8.3M	58.7M	222.4M	581.0M	622.1M	653.2M
Retained Earnings	(1.2B)	(1.3B)	(1.2B)	(924.2M)	(930.6M)	(884.1M)
Other Assets	3.6M	3.8M	368.9K	3.5M	3.2M	3.0M
Common Stock Shares Outstanding	72.0M	100.8M	133.0M	150.8M	128.7M	135.2M
Liabilities And Stockholders Equity	279.1M	353.3M	1.0B	985.9M	997.1M	1.0B
Other Stockholder Equity	1.2B	1.4B	1.4B	1.5B	1.6B	1.6B
Total Liab	270.8M	294.6M	816.9M	404.8M	375.0M	393.8M
Other Current Liab	43.8M	32.6M	201.4M	143.2M	52.5M	30.8M
Total Current Liabilities	53.0M	77.4M	556.4M	150.1M	62.2M	58.2M
Accounts Payable	9.3M	3.3M	2.6M	3.2M	5.2M	3.1M
Cash	39.9M	32.1M	436.2M	202.0M	150.3M	157.8M
Short Term Investments	111.2M	133.0M	109.8M	422.4M	592.0M	621.6M
Other Current Assets	(8.9M)	38.6M	233.4M	85.6M	19.0M	21.4M
Common Stock	84K	110K	123K	128K	130K	83.9K
Property Plant Equipment	32.0M	30.6M	61.0M	37.6M	43.2M	45.4M
Property Plant And Equipment Net	32.0M	57.2M	61.0M	63.3M	61.6M	64.7M
Net Debt	176.6M	185.8M	(178.8M)	56.0M	106.6M	112.0M
Non Current Assets Total	86.7M	124.5M	432.0M	302.0M	138.0M	144.9M
Non Currrent Assets Other	50.1M	65.1M	368.9M	236.7M	74.3M	46.8M
Cash And Short Term Investments	151.1M	165.0M	546.0M	624.4M	742.3M	779.4M
Common Stock Total Equity	84K	110K	123K	128K	147.2K	85.0K
Non Current Liabilities Total	217.7M	217.2M	260.5M	254.8M	312.8M	328.5M
Property Plant And Equipment Gross	62.3M	57.2M	61.0M	63.3M	93.4M	98.1M
Total Current Assets	192.4M	228.7M	607.3M	683.8M	859.1M	902.1M
Accumulated Other Comprehensive Income	(2.4M)	273K	(2.3M)	(5.4M)	(2.1M)	(2.2M)
Net Receivables	8.9M	22.7M	131.8M	147.5M	44.5M	46.8M
Other Liab	1.3M	2.6M	5.7M	384K	345.6K	328.3K
Good Will	2.1M	2.3M	2.1M	2.0M	2.1M	1.8M
Inventory	41.3M	63.7M	61.3M	59.4M	53.3M	56.0M
Short Long Term Debt Total	216.4M	217.8M	257.4M	258.0M	256.9M	148.9M
Long Term Debt	178.6M	179.8M	220.5M	221.6M	222.7M	233.8M
Net Tangible Assets	3.7M	56.4M	220.2M	579.0M	665.9M	699.2M
Retained Earnings Total Equity	(1.2B)	(1.3B)	(1.2B)	(924.2M)	(831.8M)	(873.4M)
Capital Surpluse	1.2B	1.4B	1.4B	1.5B	1.7B	1.1B
Non Current Liabilities Other	39.1M	37.4M	5.7M	33.2M	74K	70.3K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Dynavax Begin Period Cash Flow vs Ev To Free Cash Flow Analysis

Begin Period Cash Flow vs Ev To Free Cash Flow

Begin Period Cash Flow vs Ev To Free Cash Flow Correlation Analysis

Correlation Coefficient

Begin Period Cash Flow

Ev To Free Cash Flow

Dynavax Technologies fundamental ratios Correlations

Dynavax Technologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Dynavax Technologies fundamental ratios Accounts

Also Currently Popular

Additional Tools for Dynavax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 1.0	Common Stock
Total Current Assets	+ 1.0	Cash And Short Term Investments
Non Currrent Assets Other	+ 0.99	Other Current Liab
Current Deferred Revenue	+ 0.99	Total Current Liabilities
Property Plant And Equipment Net	+ 0.98	Common Stock Shares Outstanding
Other Current Assets	+ 0.98	Total Current Liabilities

Other Stockholder Equity	- 0.87	Retained Earnings
Property Plant Equipment	- 0.74	Retained Earnings
Common Stock Shares Outstanding	- 0.73	Retained Earnings
Property Plant And Equipment Net	- 0.7	Retained Earnings
Accounts Payable	- 0.67	Retained Earnings
Property Plant And Equipment Gross	- 0.64	Retained Earnings